Preliminary data of Non- Small Cell Lung Cancer gene expression pilot study Tõnu Vooder, Kristjan Välk, Andres Metspalu Genoa 2005.

Slides:



Advertisements
Similar presentations
Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice.
Advertisements

EUROCHIP PILOT STUDIES. Collection of detailed clinical information for specific tumours Describing and comparing care in representative samples of cancer.
Pulmonary Neoplasia Prof. Frank Carey. Lung Neoplasms r Primary l benign (rare) l malignant (very common) r Metastatic (Very common)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,
Thorax / Lung Basic Science Conference 12/21/2005 J.R. Nitzkorski.
Identification of network motifs in lung disease Cecily Swinburne Mentor: Carol J. Bult Ph.D. Summer 2007.
LUNG ADENOCARCINOMAS. CLINICOPATHOLOGICAL STUDY WITH RESPECT TO THE UPCOMING NEW CLASSIFICATION AND EGFR-KRAS MUTATION ANALYSIS IMPLICATIONS. First author:
Introduction 30-40% of all cancers arise from the epithelial lining of the aerodigestive tract. 51% & 38% of cancer deaths of men and women are from lung.
©Edited by Mingrui Zhang, CS Department, Winona State University, 2008 Identifying Lung Cancer Risks.
Huidi Liu, M.D. & Ph.D Genomics Research Centre Harbin Medical University, China Reduced expression of SOX7 in ovarian cancer: a novel.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Kelvin K. Tsai, M.D., Ph.D. Laboratory for Tumor Epigenetics and Stemness (TES Lab) NATIONAL INSTITUTE OF CANCER RESEARCH NATIONAL HEALTH RESEARCH INSTITUTES.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Age, SexHistologyPredominant subtype Pathological stage EGFR mutation CAF1 61, MaleAdenocarcinoma Solid predominant pT3N2M0 L858R CAF2 71, MaleAdenocarcinoma.
Gene Expression Signatures for Prognosis in NSCLC, Coupled with Signatures of Oncogenic Pathway Deregulation, Provide a Novel Approach for Selection of.
Bevacizumab may Differentially Improve Survival for Patients with the Proliferative and Mesenchymal Molecular Subtype of Ovarian Cancer Presented By Boris.
Prof. Yechiam Yemini (YY) Computer Science Department Columbia University (c)Copyrights; Yechiam Yemini; Lecture 2: Introduction to Paradigms 2.3.
Personalized medicine in lung cancer R4 김승민. Personalized Medicine in Lung Cancer patients with specific types and stages of cancer should be treated.
(1) Genotype-Tissue Expression (GTEx) Largest systematic study of genetic regulation in multiple tissues to date 53 tissues, 500+ donors, 9K samples, 180M.
 Lung Cancer Sydney Freedman and Rachel Rea. Causes  No exact cause  Smokers and non-smokers can get lung cancer  Smoke causes cancer by damaging.
Lung Cancer.
Smoking and Lung Cancer
Yuna Jo. Introduction Prostate cancer (PCa) continues to burden the Western world with its high rates of incidence and mortality despite the.
Main Figures and Tables
Samsung Genome Institute Samsung Medical Center
SURGICAL ONCOLOGY AND TUMOR MARKERS
Intermediate Atypical Carcinoma: Novel Histologic Subtype of mCRPC in Patients Resistant to Androgen Receptor Agonists CCO Independent Conference Highlights.
NISCHR Academic Health Science Collaboration Launch
GENETIC BIOMARKERS.
Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,
EXPRESSION OF ABERRANT p53 PROTEIN IN GASTRIC CANCER
Visualization of tissue and plasma kallikreins and kinin B1 and B2 receptors in human lung carcinomas and mesotheliomas Visualization of tissue and plasma.
EXPRESSION AND EPIGENETIC REGULATION OF KALLIKREINS AND KININ RECEPTORS IN LUNG CARCINOMA CELLS Kanti Bhoola, Yee Yen Sia, Odette Shaw, Neil Misso &
Compassionate People World Class Care
Gene expression.
Jeopardy Testing 1, 2, 3 She Has The Cancer Radiation or Chemo?
Prognosis of younger patients in non-small cell lung cancer
In Focus 6 Spotlight on Specific Cancers TANYA
The effect of aquaporin-5 knockdown on HT29 colon cancer cell proliferation and migration Y Tomita1, 2, H Dorward1, J Wrin1, RJ Vary1, ML De Ieso2, AJ.
Taipei Veterans General Hospital,
Patient Case 1 Patient Case 1: PET/CT Scan.
Limburg Clinical Research Program
RNA Sequencing Approaches to Identify Novel Biomarkers for Venous Thromboembolism (VTE) in Lung Cancer Tamara A. Sussman MD1, Mohamed Abazeed MD PhD1,
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.
Molecular pathology of non-small cell lung cancer
A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers  Hisao Asamura, MD, Tomoyuki Goya, MD, Yoshihiko Koshiishi, MD, Yasunori.
Cancer stem cells and their application into targeted therapy for cancer Mol. Bio. Lab Park Ji Won Supervisor ; Dae Youn Hwang.
Loyola Marymount University
Gene Expression Profiling of Large Cell Lung Cancer Links Transcriptional Phenotypes to the New Histological WHO 2015 Classification  Anna Karlsson, MSc,
The Changing Face of Cancer in Iowa
Learning More from Microarrays: Insights from Modules and Networks
Clinical marker confirmation using centrally assessed progression-free survival data in patients with advanced non-small cell lung cancer with non-squamous.
Why study Brain tumour Biology???
Volume 5, Issue 6, Pages e3 (December 2017)
Volume 24, Issue 12, Pages e5 (September 2018)
Christina I. Selinger, PhD, Wendy A
Cutaneous T-Cell Lymphoma: Disease, Diagnosis, and Therapy
Nat. Rev. Urol. doi: /nrurol
Loyola Marymount University
Genetics of Langerhance Cell Histiocytosis
Tracing the Innate Genetic Evolution and Spatial Heterogeneity in Treatment Naïve Lung Cancer Lesions Jihye Kim Translational Bioinformatics and Cancer.
Loyola Marymount University
Loyola Marymount University
Loyola Marymount University
Trends in survival from metastatic lung cancer in California,
EN1 expression in breast cancer and clinical outcome.
Principles and Practice of Radiation Therapy
The Role of TIPE2 Protein in Invasive Breast Carcinoma
Kaplan-Meier (K-M) curves of progression-free survival (PFS) in 54 patients with metastatic gastric cancer treated with RAD001. Kaplan-Meier (K-M) curves.
Presentation transcript:

Preliminary data of Non- Small Cell Lung Cancer gene expression pilot study Tõnu Vooder, Kristjan Välk, Andres Metspalu Genoa 2005

Introduction 1 milj. deaths in a year 5 year survival 5-15% In Estonia ~ 700 cases every year ~70 radical treatments in TU Hospital every year With the same hist. type and stage different patients have different treatment response and disease progression New possibility in lung cancer diagnostics- microarray gene expression analysis

Histological classification of lung cancer Lung Cancer Small Cell Lung Cancer Lung CancerNon-Small Cell Lung Cancer Squamous cell lung cancer Adeno-carcinoma Giant cell carcinoma

Epidemiology Rare disease at the beginning of 20 century In 1950 the relationship between the cigarette smoke and lung cancer cigarette smoke increases relative risk for 20 times 95% of lung cancer patients are smokers 10% smokers will have lung cancer Radon and asbestos

TissueTotal RNA AAA Cy3/Cy5 cRNAHybridisation Microarray detection Analysis Normalisation, Ratio statistics

Lung Cancer gene expression studies so far … Possible to distinguish small and non-small cell lung cancer, different subtypes and different molecular phenotypes in them Associations between differentiation and clinical outcome Proliferative cluster (lung and breast cancer, Chung 2002), in silico found in different cancers First and second response genes

Patient Cancer type Patient Nr. Age and gender SmokingTNMStage BA548M 10 pypT2N0M0 Ib BA2873M 50 pypT2N1M0 IIa BA4764M 18 pypT1N0M0 Ia BA5755M 35 pypT2N0M0 Ib BA5874M 40 pypT1N0M0 Ia BA838M 25 pypT2N3M0 IIIb A2152M 35 pypT1N0M0 Ia A3755M 30 pypT2N0M0 Ib A4061N 20 pypTNM1pul IV A5661M 40 pypT2N0M0 Ib

Differentially expressed genes 314 genes, which were at least 2 times ↨ regulated at least in three tumours 52 ↑ genes (30 without annotation) and 262 ↓ genes (146 without annotation) 43↓ and 5↑ genes, which had by annotation direct or indirect association with inflammation, tumorigenic processes

STEAP, DAPK1, EDG1 STEAP- Six Transmembrane Epithelial Antigen of the Prostate. Tumour specific cell surface marker. Therapy and diagnostics DAPK1- Death-Associated Protein Kinase 1, + mediator in y int. induced cell death signal pathway EDG1- Estrogen Down-regulated Gene 1, ↓, ↓ in breast cancer. If artificially ↑= proliferation restricted

A40A40 A40 A40R A37 A37R BA28 BA28R BA47 BA47R A21 A21R A56 BA57 A56R BA57R BA58 BA58R BA5 BA5R BA8 BA8R

Summary and perspectives 314 ↨ genes, 48 associated with tumours (by annotation) 3 clusters Distinguish metastases tumour Analysis of 100 different histological lung cancer samples - diagnostic TEST SNP analysis

Acknowledgments! Estonian Science FoundationEstonian Science Foundation Estonian BiocentreEstonian Biocentre